Susan Majka
Concepts (386)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung | 24 | 2024 | 3664 | 2.790 |
Why?
| Wnt Signaling Pathway | 6 | 2023 | 150 | 2.150 |
Why?
| Stem Cells | 14 | 2023 | 559 | 1.480 |
Why?
| Hypertension, Pulmonary | 17 | 2022 | 1794 | 1.390 |
Why?
| Neovascularization, Physiologic | 4 | 2020 | 181 | 1.320 |
Why?
| Cell Separation | 5 | 2020 | 296 | 1.260 |
Why?
| Adipocytes | 7 | 2022 | 199 | 1.130 |
Why?
| Cell Lineage | 10 | 2020 | 318 | 1.110 |
Why?
| Cell Differentiation | 18 | 2021 | 1753 | 1.050 |
Why?
| Adipose Tissue | 9 | 2022 | 606 | 1.010 |
Why?
| Microvessels | 2 | 2017 | 77 | 0.950 |
Why?
| Stem Cell Niche | 3 | 2020 | 43 | 0.940 |
Why?
| Lung Injury | 4 | 2019 | 210 | 0.900 |
Why?
| Pulmonary Fibrosis | 4 | 2017 | 303 | 0.870 |
Why?
| Mice | 40 | 2023 | 15520 | 0.850 |
Why?
| beta Catenin | 3 | 2020 | 219 | 0.850 |
Why?
| Fibrosis | 4 | 2019 | 483 | 0.800 |
Why?
| Endothelium, Vascular | 5 | 2020 | 907 | 0.790 |
Why?
| Pulmonary Disease, Chronic Obstructive | 7 | 2023 | 1137 | 0.780 |
Why?
| Neovascularization, Pathologic | 2 | 2020 | 287 | 0.780 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2023 | 368 | 0.780 |
Why?
| Endothelial Progenitor Cells | 1 | 2020 | 18 | 0.760 |
Why?
| Airway Remodeling | 1 | 2020 | 57 | 0.740 |
Why?
| Animals | 53 | 2023 | 33381 | 0.730 |
Why?
| Myeloid Cells | 4 | 2019 | 128 | 0.730 |
Why?
| Wnt Proteins | 1 | 2020 | 140 | 0.690 |
Why?
| Immunophenotyping | 1 | 2020 | 278 | 0.680 |
Why?
| Polycystic Kidney Diseases | 1 | 2019 | 55 | 0.680 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2020 | 369 | 0.660 |
Why?
| Bone Marrow Cells | 7 | 2021 | 273 | 0.660 |
Why?
| Pericytes | 2 | 2017 | 24 | 0.650 |
Why?
| Bone Morphogenetic Protein Receptors, Type II | 4 | 2017 | 48 | 0.650 |
Why?
| Cells, Cultured | 15 | 2020 | 4077 | 0.630 |
Why?
| PPAR gamma | 5 | 2022 | 188 | 0.620 |
Why?
| Leukocyte Common Antigens | 5 | 2011 | 76 | 0.590 |
Why?
| Flow Cytometry | 7 | 2018 | 1085 | 0.560 |
Why?
| Pulmonary Artery | 11 | 2022 | 1063 | 0.560 |
Why?
| Endothelial Cells | 5 | 2022 | 732 | 0.550 |
Why?
| Myocytes, Smooth Muscle | 7 | 2020 | 236 | 0.540 |
Why?
| Cell- and Tissue-Based Therapy | 2 | 2016 | 54 | 0.520 |
Why?
| Adipocytes, White | 2 | 2015 | 17 | 0.520 |
Why?
| ATP-Binding Cassette Transporters | 2 | 2014 | 125 | 0.500 |
Why?
| Mesoderm | 4 | 2010 | 141 | 0.490 |
Why?
| Pluripotent Stem Cells | 1 | 2014 | 65 | 0.470 |
Why?
| Cell Proliferation | 8 | 2018 | 2275 | 0.430 |
Why?
| Induced Pluripotent Stem Cells | 2 | 2011 | 185 | 0.420 |
Why?
| Lung Diseases | 4 | 2016 | 718 | 0.410 |
Why?
| Bleomycin | 3 | 2019 | 228 | 0.410 |
Why?
| Neoplasm Proteins | 1 | 2014 | 401 | 0.400 |
Why?
| Benzimidazoles | 2 | 2011 | 140 | 0.390 |
Why?
| Calcification, Physiologic | 1 | 2011 | 34 | 0.390 |
Why?
| Mice, Transgenic | 12 | 2022 | 2025 | 0.380 |
Why?
| Intra-Abdominal Fat | 1 | 2011 | 98 | 0.380 |
Why?
| Pulmonary Circulation | 3 | 2009 | 424 | 0.380 |
Why?
| Mice, Inbred C57BL | 17 | 2022 | 4908 | 0.370 |
Why?
| Osteoblasts | 1 | 2011 | 115 | 0.370 |
Why?
| Hypoxia | 9 | 2021 | 963 | 0.360 |
Why?
| Fibroblast Growth Factor 10 | 3 | 2019 | 24 | 0.360 |
Why?
| Familial Primary Pulmonary Hypertension | 5 | 2014 | 193 | 0.350 |
Why?
| Pulmonary Emphysema | 3 | 2022 | 327 | 0.350 |
Why?
| Osteogenesis | 1 | 2011 | 213 | 0.330 |
Why?
| Regeneration | 5 | 2019 | 165 | 0.320 |
Why?
| Respiratory System | 1 | 2009 | 141 | 0.320 |
Why?
| Phenotype | 7 | 2020 | 3003 | 0.310 |
Why?
| Humans | 38 | 2024 | 118972 | 0.310 |
Why?
| Mice, Knockout | 7 | 2021 | 2680 | 0.300 |
Why?
| Mutation | 2 | 2021 | 3457 | 0.280 |
Why?
| Immunomodulation | 2 | 2021 | 89 | 0.280 |
Why?
| Myofibroblasts | 2 | 2019 | 120 | 0.270 |
Why?
| Matrix Metalloproteinase 2 | 2 | 2002 | 56 | 0.270 |
Why?
| Vasoconstriction | 2 | 2017 | 213 | 0.260 |
Why?
| Apoptosis | 4 | 2013 | 2484 | 0.260 |
Why?
| Superoxide Dismutase | 3 | 2014 | 339 | 0.260 |
Why?
| Respiratory Mucosa | 2 | 2019 | 254 | 0.250 |
Why?
| Vascular Remodeling | 3 | 2022 | 152 | 0.250 |
Why?
| Coal Mining | 1 | 2024 | 9 | 0.240 |
Why?
| Pneumoconiosis | 1 | 2024 | 12 | 0.240 |
Why?
| Cell Line | 3 | 2020 | 2707 | 0.230 |
Why?
| Disease Models, Animal | 8 | 2022 | 3730 | 0.230 |
Why?
| T-Lymphocytes | 1 | 2011 | 1774 | 0.230 |
Why?
| Granuloma, Respiratory Tract | 1 | 2002 | 12 | 0.220 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2023 | 2062 | 0.220 |
Why?
| Muscle, Smooth, Vascular | 4 | 2015 | 454 | 0.220 |
Why?
| Cryptococcus neoformans | 1 | 2002 | 18 | 0.210 |
Why?
| Cryptococcosis | 1 | 2002 | 23 | 0.210 |
Why?
| Retinal Neovascularization | 1 | 2002 | 21 | 0.210 |
Why?
| Leptin | 2 | 2022 | 231 | 0.210 |
Why?
| Epithelial Cells | 4 | 2020 | 963 | 0.210 |
Why?
| Hemopexin | 1 | 2021 | 13 | 0.210 |
Why?
| Cell Hypoxia | 2 | 2020 | 220 | 0.200 |
Why?
| Potassium Channels, Tandem Pore Domain | 1 | 2021 | 11 | 0.200 |
Why?
| Fibroblasts | 3 | 2018 | 842 | 0.200 |
Why?
| Urokinase-Type Plasminogen Activator | 2 | 1999 | 30 | 0.200 |
Why?
| Matrix Metalloproteinases | 1 | 2002 | 90 | 0.200 |
Why?
| Cigarette Smoking | 1 | 2022 | 85 | 0.200 |
Why?
| Calgranulin B | 1 | 2020 | 6 | 0.190 |
Why?
| Occupational Exposure | 1 | 2024 | 277 | 0.190 |
Why?
| Tamoxifen | 2 | 2019 | 198 | 0.190 |
Why?
| Acute Lung Injury | 2 | 2017 | 310 | 0.190 |
Why?
| Male | 19 | 2020 | 57801 | 0.190 |
Why?
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2020 | 12 | 0.190 |
Why?
| Biomarkers | 5 | 2021 | 3588 | 0.190 |
Why?
| Glutathione Peroxidase | 1 | 2020 | 54 | 0.190 |
Why?
| Myocardium | 4 | 2019 | 970 | 0.180 |
Why?
| Muscle, Skeletal | 3 | 2009 | 1515 | 0.180 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2019 | 26 | 0.180 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 21 | 0.180 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2011 | 814 | 0.170 |
Why?
| RNA Stability | 1 | 2020 | 97 | 0.170 |
Why?
| Cell Culture Techniques | 2 | 2020 | 356 | 0.170 |
Why?
| Vascular System Injuries | 1 | 2020 | 70 | 0.170 |
Why?
| Receptor, Serotonin, 5-HT2B | 1 | 2018 | 2 | 0.170 |
Why?
| Smoke | 1 | 2020 | 143 | 0.170 |
Why?
| Myeloid Progenitor Cells | 1 | 2018 | 16 | 0.170 |
Why?
| Hematopoietic Stem Cells | 5 | 2022 | 359 | 0.170 |
Why?
| Laryngostenosis | 1 | 2018 | 21 | 0.170 |
Why?
| Female | 16 | 2022 | 61564 | 0.170 |
Why?
| Kidney Tubules, Proximal | 1 | 2019 | 131 | 0.160 |
Why?
| Cyclic AMP Response Element-Binding Protein | 2 | 2011 | 144 | 0.160 |
Why?
| Cicatrix | 1 | 2018 | 53 | 0.160 |
Why?
| Alveolar Epithelial Cells | 1 | 2019 | 102 | 0.160 |
Why?
| Cadherins | 1 | 2019 | 186 | 0.160 |
Why?
| Benzaldehydes | 1 | 2017 | 8 | 0.160 |
Why?
| Anemia, Sickle Cell | 1 | 2021 | 230 | 0.160 |
Why?
| Interleukin-17 | 1 | 2018 | 105 | 0.160 |
Why?
| Membrane Proteins | 2 | 2022 | 1055 | 0.160 |
Why?
| Niacinamide | 1 | 2017 | 70 | 0.150 |
Why?
| Ventricular Remodeling | 1 | 2019 | 229 | 0.150 |
Why?
| Integrin beta1 | 1 | 2017 | 20 | 0.150 |
Why?
| Inflammation Mediators | 1 | 2020 | 502 | 0.150 |
Why?
| Nerve Tissue Proteins | 1 | 2021 | 551 | 0.150 |
Why?
| Heart | 2 | 1999 | 631 | 0.150 |
Why?
| Thiazolidinediones | 2 | 2009 | 146 | 0.150 |
Why?
| Signal Transduction | 8 | 2019 | 4709 | 0.140 |
Why?
| Protein Stability | 1 | 2017 | 164 | 0.140 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2002 | 1171 | 0.140 |
Why?
| MicroRNAs | 1 | 2022 | 637 | 0.140 |
Why?
| Hemoglobins | 2 | 2021 | 326 | 0.130 |
Why?
| Hypoxia-Inducible Factor 1 | 1 | 2015 | 64 | 0.130 |
Why?
| Trans-Activators | 1 | 1997 | 373 | 0.130 |
Why?
| Promoter Regions, Genetic | 3 | 2015 | 1158 | 0.120 |
Why?
| Repressor Proteins | 1 | 1997 | 377 | 0.120 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 246 | 0.120 |
Why?
| Adult | 5 | 2020 | 31512 | 0.120 |
Why?
| Gene Expression Regulation | 5 | 2022 | 2445 | 0.120 |
Why?
| Inflammation | 3 | 2022 | 2566 | 0.120 |
Why?
| Macrophages | 3 | 2022 | 1324 | 0.120 |
Why?
| Insulin | 2 | 2022 | 2162 | 0.120 |
Why?
| Proto-Oncogene Proteins | 1 | 1997 | 618 | 0.120 |
Why?
| Cell Fusion | 2 | 2015 | 51 | 0.120 |
Why?
| Vascular Stiffness | 1 | 2018 | 425 | 0.120 |
Why?
| Animals, Newborn | 2 | 2009 | 806 | 0.120 |
Why?
| Leukocytes, Mononuclear | 2 | 2022 | 509 | 0.120 |
Why?
| Transforming Growth Factor beta1 | 1 | 2014 | 164 | 0.120 |
Why?
| Aging | 1 | 2023 | 1670 | 0.120 |
Why?
| Genetic Predisposition to Disease | 3 | 2021 | 2275 | 0.110 |
Why?
| Hydrogen Peroxide | 2 | 2012 | 305 | 0.110 |
Why?
| Polymerase Chain Reaction | 2 | 2018 | 1012 | 0.110 |
Why?
| Fatty Acid-Binding Proteins | 2 | 2023 | 62 | 0.110 |
Why?
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 7 | 0.110 |
Why?
| Models, Biological | 4 | 2021 | 1715 | 0.110 |
Why?
| ADAM Proteins | 2 | 2022 | 59 | 0.110 |
Why?
| Myocardial Infarction | 1 | 2019 | 968 | 0.110 |
Why?
| Early Growth Response Protein 1 | 2 | 2010 | 31 | 0.110 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 982 | 0.110 |
Why?
| Cytological Techniques | 1 | 2011 | 24 | 0.100 |
Why?
| Receptors, Immunologic | 1 | 2013 | 209 | 0.100 |
Why?
| Receptor, TIE-2 | 1 | 2011 | 12 | 0.100 |
Why?
| Mice, Nude | 2 | 2011 | 663 | 0.100 |
Why?
| Ventricular Pressure | 1 | 2011 | 41 | 0.100 |
Why?
| Integrin-Binding Sialoprotein | 1 | 2011 | 4 | 0.100 |
Why?
| Regenerative Medicine | 1 | 2011 | 46 | 0.100 |
Why?
| Osteocalcin | 1 | 2011 | 35 | 0.100 |
Why?
| Mice, Inbred ICR | 1 | 2011 | 111 | 0.100 |
Why?
| Adipocytes, Brown | 1 | 2010 | 6 | 0.100 |
Why?
| World Health Organization | 1 | 2011 | 107 | 0.100 |
Why?
| Cytogenetic Analysis | 1 | 2010 | 28 | 0.100 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 770 | 0.100 |
Why?
| Bone Morphogenetic Proteins | 1 | 2011 | 137 | 0.090 |
Why?
| Diet, High-Fat | 1 | 2012 | 247 | 0.090 |
Why?
| DNA-Binding Proteins | 1 | 1997 | 1346 | 0.090 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 341 | 0.090 |
Why?
| Lymphoid Progenitor Cells | 1 | 2009 | 11 | 0.090 |
Why?
| Extracellular Space | 1 | 2010 | 127 | 0.090 |
Why?
| Gene Expression Profiling | 2 | 2021 | 1597 | 0.090 |
Why?
| Bronchoconstriction | 1 | 2009 | 26 | 0.090 |
Why?
| Syndecan-4 | 1 | 2009 | 7 | 0.090 |
Why?
| Vascular Diseases | 1 | 2012 | 241 | 0.090 |
Why?
| RNA, Messenger | 4 | 2009 | 2657 | 0.090 |
Why?
| Ventricular Function, Right | 1 | 2011 | 257 | 0.090 |
Why?
| AC133 Antigen | 1 | 2008 | 20 | 0.080 |
Why?
| Giant Cells | 1 | 2008 | 22 | 0.080 |
Why?
| Satellite Cells, Skeletal Muscle | 1 | 2009 | 26 | 0.080 |
Why?
| Case-Control Studies | 4 | 2021 | 3171 | 0.080 |
Why?
| Tissue Scaffolds | 1 | 2011 | 184 | 0.080 |
Why?
| Neprilysin | 1 | 2009 | 48 | 0.080 |
Why?
| Muscle, Smooth | 1 | 2009 | 157 | 0.080 |
Why?
| Genotype | 2 | 2011 | 1882 | 0.080 |
Why?
| Hyperoxia | 1 | 2009 | 97 | 0.080 |
Why?
| Middle Aged | 5 | 2020 | 27617 | 0.080 |
Why?
| Thrombosis | 1 | 2011 | 309 | 0.080 |
Why?
| Infant, Newborn, Diseases | 1 | 2009 | 106 | 0.080 |
Why?
| Receptor for Advanced Glycation End Products | 2 | 2020 | 34 | 0.080 |
Why?
| Vasodilator Agents | 1 | 2009 | 328 | 0.070 |
Why?
| Activating Transcription Factor 1 | 1 | 2006 | 9 | 0.070 |
Why?
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 16 | 0.070 |
Why?
| Glycoproteins | 1 | 2008 | 319 | 0.070 |
Why?
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 35 | 0.070 |
Why?
| Immunohistochemistry | 2 | 2018 | 1691 | 0.070 |
Why?
| Reactive Oxygen Species | 1 | 2009 | 576 | 0.070 |
Why?
| RNA, Small Interfering | 4 | 2011 | 564 | 0.070 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2009 | 527 | 0.070 |
Why?
| Antigens, CD | 1 | 2008 | 460 | 0.070 |
Why?
| Bone Marrow Transplantation | 3 | 2019 | 244 | 0.070 |
Why?
| Cell Nucleus | 1 | 2009 | 580 | 0.070 |
Why?
| Cytokines | 3 | 2021 | 1900 | 0.070 |
Why?
| Pyrroles | 2 | 2018 | 191 | 0.060 |
Why?
| Sex Factors | 1 | 2010 | 1781 | 0.060 |
Why?
| Age Factors | 2 | 2010 | 2995 | 0.060 |
Why?
| Adiponectin | 2 | 2022 | 226 | 0.060 |
Why?
| Aged | 3 | 2020 | 19657 | 0.060 |
Why?
| Young Adult | 1 | 2020 | 10793 | 0.060 |
Why?
| Silicates | 1 | 2024 | 11 | 0.060 |
Why?
| Coal | 1 | 2024 | 15 | 0.060 |
Why?
| Microscopy, Electron, Scanning | 1 | 2024 | 196 | 0.060 |
Why?
| Indoles | 2 | 2018 | 316 | 0.060 |
Why?
| Insulin Resistance | 1 | 2012 | 1180 | 0.060 |
Why?
| Sepsis | 1 | 2009 | 531 | 0.060 |
Why?
| Dust | 1 | 2024 | 88 | 0.060 |
Why?
| Muscle Cells | 1 | 2003 | 42 | 0.060 |
Why?
| Blotting, Western | 3 | 2012 | 1194 | 0.060 |
Why?
| Silicon Dioxide | 1 | 2024 | 95 | 0.060 |
Why?
| Guanine | 1 | 2003 | 75 | 0.060 |
Why?
| Hypertrophy, Right Ventricular | 2 | 2014 | 146 | 0.060 |
Why?
| Peptides | 1 | 2008 | 879 | 0.060 |
Why?
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2002 | 11 | 0.050 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 827 | 0.050 |
Why?
| X-Ray Microtomography | 1 | 2022 | 79 | 0.050 |
Why?
| Endothelium | 1 | 2003 | 120 | 0.050 |
Why?
| Ceramides | 1 | 2022 | 104 | 0.050 |
Why?
| Diphtheria Toxin | 1 | 2022 | 63 | 0.050 |
Why?
| ADAM17 Protein | 1 | 2002 | 31 | 0.050 |
Why?
| Metalloendopeptidases | 1 | 2002 | 56 | 0.050 |
Why?
| In Situ Nick-End Labeling | 1 | 2002 | 124 | 0.050 |
Why?
| Nitric Oxide Synthase Type III | 2 | 2014 | 198 | 0.050 |
Why?
| Leukocyte Count | 1 | 2002 | 305 | 0.050 |
Why?
| Heme | 1 | 2021 | 54 | 0.050 |
Why?
| Quail | 2 | 1999 | 6 | 0.050 |
Why?
| Immunoenzyme Techniques | 1 | 2002 | 195 | 0.050 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2002 | 127 | 0.050 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 147 | 0.050 |
Why?
| Phosphoproteins | 2 | 2017 | 308 | 0.050 |
Why?
| Leukocytes | 1 | 2022 | 290 | 0.050 |
Why?
| Cell Division | 3 | 2009 | 776 | 0.050 |
Why?
| Wound Healing | 1 | 2003 | 270 | 0.050 |
Why?
| Hemolysis | 1 | 2021 | 174 | 0.050 |
Why?
| Hematopoiesis | 1 | 2001 | 175 | 0.050 |
Why?
| Models, Animal | 1 | 2002 | 363 | 0.050 |
Why?
| Vital Capacity | 1 | 2020 | 260 | 0.050 |
Why?
| Enzyme Inhibitors | 1 | 2003 | 827 | 0.040 |
Why?
| Lymphocytes | 1 | 2021 | 347 | 0.040 |
Why?
| Benzodioxoles | 1 | 2020 | 84 | 0.040 |
Why?
| Rats | 3 | 2013 | 5392 | 0.040 |
Why?
| Epithelium | 1 | 2020 | 305 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2021 | 331 | 0.040 |
Why?
| Obesity | 1 | 2012 | 2746 | 0.040 |
Why?
| Hepatocyte Growth Factor | 1 | 1999 | 33 | 0.040 |
Why?
| Arterioles | 1 | 2018 | 46 | 0.040 |
Why?
| Stem Cell Transplantation | 3 | 2006 | 153 | 0.040 |
Why?
| Quinazolines | 1 | 2020 | 245 | 0.040 |
Why?
| Infant, Newborn | 1 | 2009 | 5255 | 0.040 |
Why?
| Monocytes | 1 | 2021 | 513 | 0.040 |
Why?
| Biopsy, Needle | 1 | 2018 | 190 | 0.040 |
Why?
| Proto-Oncogene Protein c-ets-2 | 1 | 1997 | 3 | 0.040 |
Why?
| Enzyme Activation | 1 | 2020 | 828 | 0.040 |
Why?
| Cell Adhesion | 1 | 2019 | 443 | 0.040 |
Why?
| Transfection | 2 | 2013 | 888 | 0.040 |
Why?
| Proto-Oncogene Proteins c-ets | 1 | 1997 | 51 | 0.040 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1997 | 80 | 0.040 |
Why?
| DNA Primers | 2 | 2009 | 533 | 0.040 |
Why?
| Drug Evaluation, Preclinical | 1 | 2017 | 180 | 0.040 |
Why?
| Reference Values | 1 | 2018 | 774 | 0.040 |
Why?
| Embryo, Nonmammalian | 1 | 1997 | 176 | 0.040 |
Why?
| Rats, Sprague-Dawley | 2 | 2013 | 2478 | 0.040 |
Why?
| Angiogenesis Inhibitors | 1 | 2018 | 219 | 0.040 |
Why?
| Echocardiography | 1 | 2019 | 556 | 0.040 |
Why?
| Adipogenesis | 1 | 2017 | 47 | 0.040 |
Why?
| Fibrin | 1 | 2017 | 60 | 0.040 |
Why?
| Bioengineering | 1 | 2016 | 13 | 0.040 |
Why?
| Disease Progression | 1 | 2023 | 2490 | 0.040 |
Why?
| Blood Pressure | 2 | 2014 | 1664 | 0.040 |
Why?
| Hemodynamics | 2 | 2012 | 1003 | 0.030 |
Why?
| RNA | 1 | 2002 | 833 | 0.030 |
Why?
| Transcriptome | 1 | 2021 | 756 | 0.030 |
Why?
| Treatment Outcome | 1 | 2009 | 9342 | 0.030 |
Why?
| Muscle Development | 2 | 2009 | 102 | 0.030 |
Why?
| GTP Cyclohydrolase | 1 | 2014 | 7 | 0.030 |
Why?
| Soluble Guanylyl Cyclase | 1 | 2014 | 15 | 0.030 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2014 | 22 | 0.030 |
Why?
| Guanylate Cyclase | 1 | 2014 | 36 | 0.030 |
Why?
| Estrogen Antagonists | 1 | 2014 | 39 | 0.030 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 394 | 0.030 |
Why?
| Cyclic GMP | 1 | 2014 | 109 | 0.030 |
Why?
| Heart Ventricles | 1 | 2019 | 727 | 0.030 |
Why?
| Genome, Human | 1 | 2016 | 387 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2017 | 870 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2018 | 1795 | 0.030 |
Why?
| Monocrotaline | 1 | 2013 | 35 | 0.030 |
Why?
| S100 Proteins | 1 | 2013 | 35 | 0.030 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 195 | 0.030 |
Why?
| Cyclic N-Oxides | 1 | 2012 | 31 | 0.030 |
Why?
| Infusion Pumps | 1 | 2012 | 32 | 0.030 |
Why?
| Glycation End Products, Advanced | 1 | 2013 | 67 | 0.030 |
Why?
| Chronic Disease | 2 | 2009 | 1636 | 0.030 |
Why?
| Smoking | 1 | 2020 | 1487 | 0.030 |
Why?
| Societies, Medical | 1 | 2016 | 703 | 0.030 |
Why?
| Spin Labels | 1 | 2012 | 50 | 0.030 |
Why?
| Arterial Pressure | 1 | 2013 | 99 | 0.030 |
Why?
| Cardiac Output | 1 | 2012 | 147 | 0.030 |
Why?
| Lipid Peroxidation | 1 | 2012 | 156 | 0.030 |
Why?
| Rats, Inbred WKY | 1 | 2011 | 38 | 0.030 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 175 | 0.030 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 540 | 0.030 |
Why?
| Naphthalenes | 1 | 2011 | 41 | 0.030 |
Why?
| Proteins | 1 | 1997 | 938 | 0.030 |
Why?
| Time Factors | 1 | 2002 | 6412 | 0.030 |
Why?
| Free Radical Scavengers | 1 | 2011 | 88 | 0.020 |
Why?
| STAT3 Transcription Factor | 1 | 2013 | 189 | 0.020 |
Why?
| RNA Interference | 1 | 2013 | 460 | 0.020 |
Why?
| Nitrosation | 1 | 2010 | 10 | 0.020 |
Why?
| Gene Expression | 2 | 2008 | 1489 | 0.020 |
Why?
| Risk Factors | 1 | 2023 | 9000 | 0.020 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2011 | 176 | 0.020 |
Why?
| Colony-Forming Units Assay | 1 | 2009 | 93 | 0.020 |
Why?
| Genome-Wide Association Study | 1 | 2016 | 1323 | 0.020 |
Why?
| Transcription Factors | 1 | 1997 | 1570 | 0.020 |
Why?
| Up-Regulation | 1 | 2013 | 872 | 0.020 |
Why?
| Tyrosine | 1 | 2010 | 233 | 0.020 |
Why?
| Syndecan-3 | 1 | 2009 | 7 | 0.020 |
Why?
| PAX7 Transcription Factor | 1 | 2009 | 9 | 0.020 |
Why?
| Neoplasms | 1 | 2003 | 2179 | 0.020 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 420 | 0.020 |
Why?
| Child | 1 | 2008 | 19129 | 0.020 |
Why?
| Active Transport, Cell Nucleus | 1 | 2009 | 113 | 0.020 |
Why?
| Capillary Permeability | 1 | 2009 | 140 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 2010 | 462 | 0.020 |
Why?
| Perilipin-1 | 1 | 2006 | 16 | 0.020 |
Why?
| Microscopy, Phase-Contrast | 1 | 2006 | 19 | 0.020 |
Why?
| Oxidation-Reduction | 1 | 2010 | 940 | 0.020 |
Why?
| Transcriptional Activation | 1 | 2009 | 348 | 0.020 |
Why?
| Collagenases | 1 | 2006 | 22 | 0.020 |
Why?
| Cell Movement | 1 | 2011 | 896 | 0.020 |
Why?
| 3T3-L1 Cells | 1 | 2006 | 35 | 0.020 |
Why?
| CD11 Antigens | 1 | 2006 | 32 | 0.020 |
Why?
| Stress, Physiological | 1 | 2010 | 415 | 0.020 |
Why?
| Nitric Oxide | 1 | 2012 | 892 | 0.020 |
Why?
| Blood Vessels | 1 | 2008 | 187 | 0.020 |
Why?
| Heart Failure | 1 | 2019 | 1969 | 0.020 |
Why?
| Microfilament Proteins | 1 | 2007 | 134 | 0.020 |
Why?
| Oxidative Stress | 1 | 2012 | 1178 | 0.020 |
Why?
| Muscle Proteins | 1 | 2007 | 219 | 0.020 |
Why?
| Antioxidants | 1 | 2009 | 564 | 0.020 |
Why?
| Green Fluorescent Proteins | 1 | 2006 | 395 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2008 | 1308 | 0.020 |
Why?
| Kidney | 1 | 2012 | 1353 | 0.020 |
Why?
| Dietary Fats | 1 | 2006 | 322 | 0.020 |
Why?
| Base Sequence | 1 | 2008 | 2159 | 0.020 |
Why?
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2003 | 5 | 0.010 |
Why?
| Carmustine | 1 | 2003 | 47 | 0.010 |
Why?
| Metabolic Clearance Rate | 1 | 2003 | 113 | 0.010 |
Why?
| Half-Life | 1 | 2003 | 147 | 0.010 |
Why?
| Antineoplastic Agents, Alkylating | 1 | 2003 | 69 | 0.010 |
Why?
| Proto-Oncogene Proteins c-kit | 1 | 2003 | 64 | 0.010 |
Why?
| Cell Survival | 1 | 2006 | 1047 | 0.010 |
Why?
| Infusions, Intravenous | 1 | 2003 | 380 | 0.010 |
Why?
| Carrier Proteins | 1 | 2006 | 726 | 0.010 |
Why?
| Radiation Chimera | 1 | 2001 | 31 | 0.010 |
Why?
| Cell Transplantation | 1 | 2001 | 39 | 0.010 |
Why?
| Myocardial Reperfusion Injury | 1 | 2001 | 105 | 0.010 |
Why?
| Organ Specificity | 1 | 2001 | 278 | 0.010 |
Why?
| United States | 1 | 2016 | 12555 | 0.010 |
Why?
| Myocardial Ischemia | 1 | 2001 | 251 | 0.010 |
Why?
| Hypoglycemic Agents | 1 | 2006 | 1032 | 0.010 |
Why?
| Chick Embryo | 1 | 1999 | 129 | 0.010 |
Why?
| Graft Survival | 1 | 2001 | 504 | 0.010 |
Why?
| Rabbits | 1 | 1999 | 780 | 0.010 |
Why?
|
|
Majka's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|